Experts have developed a new PET imaging method that could enhance understanding of COVID-19's long-term effects, particularly in patients experiencing lingering symptoms. Researchers from Paris-Saclay University detailed their findings in Nature Communications, highlighting a specialized radiolabeled monoclonal antibody that targets a spike protein of the virus. This radiotracer allows for the longitudinal tracking of COVID-19, potentially improving insights into long COVID's impact on health. In a study involving primates, the tracer showed significant uptake in the lungs and specific brain regions of those exposed to the Delta variant compared to a control group, indicating possible areas of viral impact. Although the sample size is small, the team believes their technology could lead to better monitoring and understanding of long COVID. Additionally, updates to the HeartSee technology, which has been used for diagnosing coronary artery disease since 2018, aim to enhance diagnostic performance and access for clinicians, reflecting changes in cardiac evaluation practices.
Tue, 25 Mar 2025 17:54:07 GMT | Health Imaging